Advertisement
Person › Details
Dušan Orešanský (NewCap. – Investor Relations & Financial Communications)
Orešanský, Dušan (NewCap 201404)
Organisation | NewCap. – Investor Relations & Financial Communications | |
Product | public relations / investor relations / marcom (services) | |
Product 2 | LIFE SCIENCES | |
Record changed: 2021-09-07 |
Advertisement
More documents for Dušan Orešanský
- [1] Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris....
- [2] ASIT Biotech S.A.. (2/23/18). "Press Release: ASIT Biotech Successfully Completes the Second Tranche of Its Capital Increase, Reaching a Total Amount Raised of €13.9 Million [Not for United States, Australia, Canada, Japan, et al.]". Brussels....
- [3] ASIT Biotech S.A.. (1/25/18). "Press Release: ASIT Biotech Successfully Completes the First Tranche of Its Capital Increase and Raises €9.4 Million [Not for United States, Australia, Canada, Japan, et al.]". Brussels....
- [4] Genticel S.A.. (2/28/17). "Press Release: Genticel Announces Its 2016 Annual Results". Paris & Toulouse....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top